Synergism Effect between Phenolic Metabolites and Endogenous Antioxidants in Terms of Antioxidant Activity by Noguer, María et al.
Advances in Chemical Engineering and Science, 2014, 4, 258-265 
Published Online April 2014 in SciRes. http://www.scirp.org/journal/aces 
http://dx.doi.org/10.4236/aces.2014.42029  
How to cite this paper: Noguer, M., et al. (2014) Synergism Effect between Phenolic Metabolites and Endogenous Antioxi-
dants in Terms of Antioxidant Activity. Advances in Chemical Engineering and Science, 4, 258-265.  
http://dx.doi.org/10.4236/aces.2014.42029  
 
 
Synergism Effect between Phenolic 
Metabolites and Endogenous Antioxidants 
in Terms of Antioxidant Activity 
María Noguer, Ana B. Cerezo, M. Luisa Moyá, Ana M. Troncoso, 
M. Carmen García-Parrilla* 
Nutrición y Bromatología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain 
Email: *mcparrilla@us.es  
 
Received 18 February 2014; revised 15 March 2014; accepted 22 March 2014 
 
Copyright © 2014 by authors and Scientific Research Publishing Inc. 
This work is licensed under the Creative Commons Attribution International License (CC BY). 
http://creativecommons.org/licenses/by/4.0/ 
  
 
 
 
Abstract 
Polyphenolic compounds, widely distributed in plant kingdom, have been exhaustively studied for 
their bioactive properties specially antioxidant activity. However, they are extensively metabo-
lized by human organism and the resulting metabolites are largely responsible for their effects. 
Furthermore, they may interact with the endogenous antioxidant network being this possibility 
scarcely studied. Plasma antioxidant network encompasses antioxidant enzymes and other sub-
stances such as uric acid. In addition, ascorbic acid is the major compound representing water so-
luble compartment both in foods and human body. The interaction of this vitamin with phenolic 
compound is largely unexplored. This work aims to study if there is a synergic effect between 
phenolic metabolites and main antioxidants (uric and ascorbic acid). For this purpose, the antioxi-
dant activity was evaluated in terms of ORAC (oxygen radical absorbance capacity) and FRAP (ferric- 
reducing antioxidant power) as these tests involved either HAT (Hydrogen Atom Transfer) or SET 
(Single Electron Transfer) mechanisms. Additionally, a kinetic studied was developed to test if the 
rate constant presented a synergic effect. Protocatechuic acid, 3,4-dihydroxyphenylacetic acid, 
3,4-dihydroxyphenylpropionic acid and 3-hydroxyphenylacetic acid were selected as they were 
metabolites of polyphenol compounds such as anthocyanins, quercetin, neohesperidin, chloro-
genic acid and hesperetin present in wines, orange and strawberries. A synergic effect was proved 
for the combination of ascorbic acid with 3,4-dihydroxyphenylacetic acid, both in terms of anti-
oxidant activity and potent increase of velocity of the antioxidant reaction that took place. 
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1. Introduction 
Phenolic compounds present in wines and in many other foods and beverages exhibit marked antioxidant activity 
and their in vitro antioxidant properties have been studied in depth [1]-[4]. Methods to assess the antioxidant ac-
tivity are based on Hydrogen Atom Transfer (HAT) and others on Single Electron Transfer (SET). Both detect 
the ability of a potential antioxidant to either scavenge a radical or to transfer one electron to reduce any com-
pound, including radicals. The end result is the same, regardless of mechanism, but kinetics and potential for side 
reactions differ [5]. Hence, ORAC (oxygen radical absorbance capacity) method is based on a hydrogen atom 
transfer (HAT) reaction mechanism and FRAP (ferric-reducing antioxidant power) assay is a SET-based method.  
Moreover, the correlation between antioxidant activity and the phenolic composition has been considered by 
different authors for different foods and beverages, including wine and strawberries, among others [6]-[10], fol-
lowing that the different categories of phenolic compounds are contributing in a different extent to the final an-
tioxidant capacity. Depending on the antioxidant assay employed this contribution can range between 12.8 - 20% 
and 32% - 40% for phenolic acids, and anthocyanins and flavanols, respectively [4]. 
At the human body level, the biological antioxidant defense encompasses an array of mechanisms including 
antioxidant enzymes (CAT, SOD, GPx,GR), endogenous antioxidants (glutation, uric acid, albumin) and dietary 
antioxidants (vitamins C, A, and E, Se, carotenoids and polyphenols) among other bioactive compounds [11]. 
However, after ingestion, dietary (poly)phenols appear in the circulatory system not as the parent compounds, 
but as phase II metabolites, and their presence in plasma after dietary intake rarely exceeds nM concentrations. 
Substantial quantities of both the parent compounds and their metabolites pass to the colon where they are de-
graded by the action of the local microbiota, giving rise principally to small phenolic acid and aromatic com-
pounds that are absorbed into the circulatory system [12]. Several phenolic acids (protocatechuic acid, 3,4- 
dihydroxyphenylacetic acid, 3,4-dihydroxyphenylpropionic acid and 3-hydroxyphenylacetic acid) are examples 
of these metabolites coming from dietary polypehnols. 
On the other hand, antioxidant activity effect can be determined both by the total moles of radicals scavenged 
and by the velocity they react to remove the radical from the media. This is of particular biological significance 
since the faster the reaction takes places the lesser the biological targets are damaged. At the same time, at the 
biological level we have many antioxidants available, and as a result they may act synergistically.  
The aim of this work is to evaluate the kinetics and synergism of different antioxidants (vitamin C, uric acid), 
and polyphenol metabolites (protocatechuic acid, 3,4-dihydroxyphenylacetic acid, 3,4-dihydroxy-phenylpro- 
pionic acid and 3-hydroxyphenylacetic acid) that are present in biological fluids as a consequence of the inges-
tion of polyphenol-rich foods. 
2. Material and Methods 
2.1. Samples 
A total of 19 aqueous standards’s solutions of different antioxidants (uric acid, ascorbic acid) and metabolites of 
phenolic compounds (protocatechuic acid, 3,4-dihydroxyphenylacetic acid, 3,4-dihydroxyphenylpropionic acid 
and 3-hydroxyphenylacetic acid) were prepared. The final concentrations assessed were 0.416 mM. 
2.2. Chemicals 
The chemicals and stardand compounds were purchased from Cayman Chemical Company [2,2’-azobis-(2- 
amidinopropane)-dihydrochloride (AAPH)], Fluka [fluorescein], Sygma-Aldrich [ferric 2,4,6-tripyridyl-s-triazine 
(TPTZ), acetic acid and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), uric acid, proto- 
catechuic acid, 3,4-dihydroxyphenylacetic acid, 3,4-dihydroxyphenylpropionic and 3-hydroxyphenylacetic acid] 
and Merck [ascorbic acid]. 
2.3. ORAC Method 
Fluorimetric measurements were recorded in F-2500 Fluorescence Spectrophotometer Hitachi and temperature 
control P-SelecterTectron Bio at 37˚C. A total of 150 µl of solution problem, 150 µl fluorescein solution (2.934 
mg/L) and 75 µl AAPH (221.25 mM) were mixed in a fluorimetric cuvette. Fluorescence was recorded for 60 
min until the final value is less than 5% of the initial value (excitation wavelength is set at 490 nm; emission 
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wavelength is set at 515 nm). Trolox solution (20 µM) was used as standard. Phosphate buffer (PBS) (75 mM, 
pH 7) was used instead of the sample to assay the blank. A triplicated was performed in every case. Results are 
calculated as ORAC values using areas under the fluorescein decay curve between the blank and the sample and 
are expressed as Trolox Equivalents [4]. 
2.4. FRAP Method 
This procedure is based on a Single Electron Transfer (SET) reaction mechanism, as follows: 
( ) ( )3 22 2Fe TPTZ ArOH Fe TPTZ +ArOH
+ + ++ →                         (1) 
Equation (1) expresses the redox reaction when the ferric tripyridyltriazine complex ( ( )32Fe TPTZ
+ ) is re-
duced by the antioxidant compound (ArOH) to the ferrous form ( ( )32Fe TPTZ
+ ) releasing the oxidised form of 
the antioxidant compound (ArOH+). 
Absorbance measurements were recorded on a U-2800 Spectrophotometer Digilab Hitachi at 25˚C.GLP22 
Crison pH-meter was used for buffer preparation. Briefly, 3 ml of FRAP reactive: (10:1:1) acetate buffer (300 
mM, pH 3, 6), TPTZ (10Mm in HCl 40 Mm) and FeCl3∙6H2O (20 mM); 100 µl problem solution, and 300 µl 
mili Q water. Although the method proposed to determine the absorbance at 4 min, we monitored the reaction 
until finished for each compound at 593 nm. Data were translated into FRAP value (µM) using an aqueous solu-
tion of FeSO4∙7H2O in the range of 0 - 1000 µM [13]. 
3. Results and Discussion 
3.1. Antioxidant Activity Values 
For comparative purposes, Table 1 shows the antioxidant activity values for each compound obtained by ORAC 
and FRAP methods at equimolar concentrations. Uric acid presents a stable and a well known concentration in 
plasma ranging between 0.277 - 0.416 mM. Hence, we selected 0.416 mM as a reference concentration to com-
pare the compounds under study in terms of antioxidant activity. 
Different mechanisms are involved in both antioxidant methods. Thus, ORAC method is based on the evalua-
tion of the oxidative damage produced by peroxyl radical against fluorescein, as a consequence fluorescence de-
crease. The peroxyl radical is generated by thermic decomposition of AAPH. After that, the radical react with 
the fluorescein and the decrease of fluorescence signal is measured. In the presence of an antioxidant compound 
(ArOH), the reaction with the fluorescein is delayed and a phase of retard is produced. The higher the efficacy of 
the antioxidant compound for scavenging free radicals, the lower the decrease of the florescein intensity, that is, 
the area under the curve (intensity emission/time) would be higher [14]: 
. .ROO ArOH ArO ROOH+ → +                               (2) 
Equation (2) shows the HAT mechanism of ORAC method, as follows: an antioxidant compound (ArOH) in 
presence of a peroxyl radical (ROO.) transfer a hydrogen atom and transform it in other compounds less harmful 
(ROOH). 
 
Table 1. Antioxidant activity values of standard compounds determined by ORAC and FRAP methods.                   
Compounds 
Antioxidant activity values 
ORAC 
(µm Trolox/mmolcompund) 
FRAP 
(µM Fe2+/mmolcompund) 
Uric acid 7015.3 ± 498.5 854.4 ± 79.7 
Ascorbic acid 22685.8 ± 1257.1 782.7 ± 21.7 
Protocatechuic acid 20582.9 ± 688.4 2315.4 ± 53.1 
3,4-dihydroxyphenylacetic acid 10048.1 ± 240.4 4303.4 ± 57.3 
3,4-dihydroxyphenylpropionic acid 23093.9 ± 472.1 3539.6 ± 159.4 
3-hydroxyphenylacetic acid 1844.2 ± 179.8 543.8 ± 14.4 
*Compounds concentration 0.416 mM. 
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On the other hand, FRAP method is based on SET mechanism. The reaction measure an oxide-reduction of 
ferric-tripyridyltriazine (FeIII-TPTZ) complex to the ferrous (FeII) form in the presence of an antioxidant (1). An 
intense blue color with an absorption maximum at 593 nm is measured [13]. 
In summary, it could be established that ascorbic acid and 3,4-dihydroxyphenylpropionic acid, whose activity 
rank for the higher values when determined by ORAC methods, work by a HAT mechanism. Therefore, those 
compounds have higher antioxidant activity in the biological systems in which HAT mechanism is prevalent. 
Thus, biological pH is close to that of ORAC method. It is relevant the case of ascorbic acid, since it is the prin-
cipal exogenous antioxidant present in many foods. 
On the other hand, antioxidants which rank for the higher reactivity by FRAP method, such as 3,4-dihydroxy- 
phenyacetic acid, may involve a SET mechanism. Protocatechuic acid, uric acid and 3-hydroxyphenylacetic acid 
displays a similar ranking by both methods. Therefore, they could act equally by HAT or SET. 
3.2. Kinetic Study 
The velocity of reaction (v) is relevant from a physiological point because it is important that antioxidants scav-
enge the radicals before they react with the target and produce oxidative damage. 
ORAC method involves radicals’ production and its reaction with the target molecule (fluorescein). Fluo-
rescein (FL) is always in excess, that is, its concentration is higher than the radical. Although the radical con-
centration decreases because of the antioxidant, fluorescein will not significantly be affected. Therefore, the ex-
perimentally observed rate constant, kobs, remains constant. 
On the other hand, FRAP method measure the absorbance of the FeII-TPTZ complex with the ligand (L). The 
antioxidant present in the medium drive to the formation of FeII by reduction of FeIII. Since the FeIII-TPTZ com-
plex is in excess the velocity of reaction will be determinate by the FeII formed, which will depend on the anti-
oxidant concentration. Thus, FRAP method allow to assess the velocity of the reaction taking place because it is 
a direct measure, that is, the reaction velocity is determined by the concentration of the FeII complex formed 
with the ligand and the concentration of the antioxidant.  
The reaction rate equation can be expressed as: 
( ) ( )II obsv k(Fe L) ArOH k ArOH= =                              (3) 
Here k is the second order rate constant and kobs = k(FeIIL). One can write: 
( ) ( )obsv d ArOH dt k ArOH= − =                                (4) 
And integrating are obtains: 
( ) ( ) obs*t 0Ln ArOH Ln ArOH k t= −                               (5) 
Here (ArOH)0 and (ArOH)t are the antioxidant concentration at t = 0 and t = certain time, respectively. 
Absorbance is proportional to the FeII-TPTZ concentration.The final absorbance, Af, is proportional to the fi-
nal FeII-TPTZ concentration, that is, to the initial antioxidant concentration. Absorbance at a certain time, At, is 
proportional to the FeII-TPTZ concentration formed. Therefore, Af-At is proportional to the remaining antioxi-
dant concentration at certain time. Thus, Equation (5) can be explained as: 
( ) obs*Ln Af At a K t− = −                                     (6) 
Here a is a constant proportional to the initial antioxidant concentration. 
Information about the antioxidant activity of the different antioxidants can be obtained from the calculated 
kobs values (Figure 1, Table 2). It is worth noting that the absorbance values were registered during a 480 s time 
interval in order to make sure that the oxidation reaction is finished for all the antioxidants investigated (see 
Figure 2 for uric acid and3,4-dihydroxyphenylacetic acid). 
3.3. Evaluation of Synergism: Antioxidant Activity Values and Kinetic Criteria 
In order to evaluate the synergism between different compounds, the antioxidant activity (ORAC and FRAP me- 
thods) of different combinations of selected endogenous (uric acid) and exogenous (ascorbic acid and phenolic 
metabolites) compounds was determined. 
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Figure 1. Slope for observed rate constant of compounds.                      
 
 
Figure 2. Absorbance values for uric acid and 3,4-dihydroxyphenylacetic acid de-
termined by FRAP method.                                              
 
Table 2. Observed rate constant valuefor the different compounds. 
Compounds* Observed rate constant (Kobs/s−1) 
Uric acid 0.007 
Ascorbic acid 0.007 
Protocatechuic acid 0.012 
3,4-dihydroxyphenylacetic acid 0.013 
3,4-dihydroxyphenylpropionic acid 0.013 
*Compounds concentration 0.416 mM. 
 
Table 3 and Table 4 show experimental and theoretical antioxidant activity values for different combinations 
of compounds determined by ORAC and FRAP, respectively. Experimental value was obtained by assessing a  
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Table 3. Antioxidant activity values for the combination of the different compounds determined by ORAC method.         
Compounds* 
Antioxidant activity values by ORAC (µM trolox) 
Experimental measurements Theoretical measurements Synergism 
Uric acid + ascorbic acid 4221.8 ± 363.3a 12355.6 ± 459.3b NO 
uric acid + Protocatechuic acid 12150.0 ± 410.1 11480.8 ± 288.7 X 
Uric acid + 3,4-dihydroxyphenylacetic acid 6636.6 ± 600.2 7098.4 ± 178.9 X 
Uric acid + 3,4-dihydroxyphenylpropionic acid 9888.0 ± 916.4 12529.4 ± 207.6 X 
Uric acid + 3-hydroxyphenylacetic acid 1009.7 ± 372.7a 3685.3 ± 174.6b NO 
Ascorbic acid + Protocatechuic acid 11615.0 ± 3174.0 17999.8 ± 486.8 X 
Ascorbic acid + 3,4-dihydroxyphenylacetic acid 16773.1 ± 836.7a 13617.3 ± 430.8b YES 
Ascorbic acid + 3,4-dihydroxyphenylpropionic acid 1050.6 ± 75.6a 19048.3 ± 443.5b NO 
Ascorbic acid + 3-hydroxyphenylacetic acid 1973.5 ± 172.9a 10204.3 ± 429.1b NO 
Uric acid + ascorbic acid + protocatechuic acid 31575.5 ± 5456.7a 20918.2 ± 477.2b YES 
Uric acid + Ascorbic acid + 3,4-dihydroxyphenylacetic acid 6662.3 ± 109.1a 16535.6 ± 428.6b NO 
Uric acid + Ascorbic acid + 3,4-dihydroxyphenylpropionic acid 10919.6 ± 1618.8a 21966.6 ± 439.5b NO 
Uric acid + Ascorbic acid + 3-hydroxyphenylacetic acid 7495.6 ± 347.1a 13122.6 ± 427.1b NO 
*Compounds concentration 0.416 mM. absuperscript letters in the same column indicate significant differences (p < 0.05); NO: experimental mea-
surement was significantly lesser than theoretical measurement; X: no significant differences between experimental and theoretical measure-
mentswere observed; YES: experimental measurements was significantly higher than theoretical measurements. 
 
Table 4. Antioxidant activity values for the combination of the different compounds determined by FRAP method.          
Compounds* 
Antioxidant activity values by FRAP (µM Fe2+) 
Experimental measurements Theoretical measurements Sinergism 
Uric acid+ascorbic acid 2210.6 ± 66.3a 681.1 ± 28.1b YES 
uric acid+ Protocatechuic acid 1404.6 ± 4.4 1318.7 ± 32.5 X 
Uric acid+3,4-dihydroxyphenylacetic acid 1641.8 ± 25.3 2145.7 ± 33.4 X 
Uric acid+3,4-dihydroxyphenylpropionic acid 4491.8 ± 66.3a 1827.9 ± 60.5b YES 
Uric acid+3-hydroxyphenylacetic acid 46.6 ± 1.0 581.6 ± 27.5 NO 
Ascorbic acid+Protocatechuic acid 1014.0 ± 8.8 1288.8 ± 19.5 X 
Ascorbic acid+3,4-dihydroxyphenylacetic acid 839.0 ± 8.8a 2115.8 ± 22.5b NO 
Ascorbic acid+3,4-dihydroxyphenylpropionic acid 304.4 ± 22.1a 1798.1 ± 54.6b NO 
Ascorbic acid+3-hydroxyphenylacetic acid 51.9 ± 11.5a 551.8 ± 8.8b NO 
Uric acid+ascorbic acid+protocatechuic acid 1402.2 ± 33.2 1647.9 ± 30.8 X 
Uric acid+Ascorbic acid+3,4-dihydroxyphenylacetic acid 4913.7 ± 88.4a 2471.2 ± 32.5b YES 
Uric acid+Ascorbic acid+3,4-dihydroxyphenylpropionic acid 710.6 ± 22.1a 2153.5 ± 56.4b NO 
Uric acid+Ascorbic acid+3-hydroxyphenylacetic acid 198.4 ± 16.9a 907.2 ± 26.3b NO 
*Compounds concentration 0.416 mM. absuperscript letters in the same column indicate significant differences (p < 0.05); NO: experimental mea-
surement was significantly lesser than theoretical measurement; X: no significant differences between experimental and theoretical measurements 
were observed; YES: experimental measurements was significantly higher than theoretical measurements. 
 
mix of compounds. While theoretical value was calculated by summing the values obtained for each compound 
individually. 
It was observed a synergism effect in the combination of ascorbic acid with 3,4-dihydroxyphenylacetic acid, 
and ascorbic acid with uric acid and protocatechuic acid rising 1.2 and 1.5 fold their theoretical values respec-
tively, when they were measured by ORAC. According to the FRAP method, synergic effect was shown for dif-
ferent combinations of compounds: uric acid with ascorbic acid; uric acid with 3,4-dihydroxyphenylpropionic, 
and uric acid with ascorbic acid and 3,4-dihydroxyphenylacetic acid, increasing 3.23, 2.45 and 2 folds their 
theoretical values, respectively. 
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Table 5. Observed rate constant values for the different compounds.          
Compounds Observed rate constant (Kobs/s−1) 
Protocatechuic acid + uric acid 0.012 
Protocatechuic acid + ascorbic acid 0.012 
Protocatechuic acid + uric acid + ascorbic acid 0.012 
3,4-dihydroxyphenylacetic acid + uric acid 0.005 
3,4-dihydroxyphenylacetic acid + ascorbic acid 0.190 
3,4-dihydroxyphenylacetic acid + uric acid + ascorbic acid 0.004 
3,4-dihydroxyphenylpropionic acid + uric acid 0.010 
3,4-dihydroxyphenylpropionic acid + ascorbic acid 0.010 
3,4-dihydroxyphenylpropionic acid + uric acid + ascorbic acid 0.010 
 
Finally synergism was evaluated in kinetic terms and the constants of the different combinations were deter-
mined (Table 5). As can be seen the combination of ascorbic acid with 3,4-dihydroxyphenylacetic acid pre-
sented the highest rate constant, showing a potent synergism effect being relevant for biological perspective. 
Hence, this combination includes both aspects antioxidant activity itself and a marked reaction rate. 
3,4-Dihydroxyphenylacetic acid is a metabolite produced by the colonic microbiota [15] [16], from flavonoids 
(anthocyanin and quercetin). This metabolite proved to preserve neuron cell from death due to oxidative stress 
[16]. Additionally, this metabolite is a powerful inhibitor of Nε-carboxymethyl lysine and Nε-carboxymethyl ly-
sine-histone H1 adduct formation and ADP-ribose histone H1glycation [17]. Furthermore, 3,4-dihydroxypheny- 
lacetic acid has been demonstrated to act as an anti-inflammatory agent, probably contributing to the chemopre-
ventive potential of phenolic metabolites in the gut [18]. 
4. Conclusion 
In conclusion, we have established that there is synergism effect between exogenous antioxidants (ascorbic acid 
and 3,4-dihydroxyphenylacetic acid) and between endogenous and exogenous antioxidants (ascorbic acid, uric 
acid and protocatechuic acid; uric acid and ascorbic acid; uric acid and 3,4-dihydroxyphenylpropionic acid, and 
uric acid, ascorbic acid and 3,4-dihydroxyphenylacetic acid). Additionally, the combination of ascorbic acid 
with the colonic microbiota metabolite 3,4-dihydroxyphenylacetic acid showed a potent synergism effect rele-
vant for biological perspective due to its market reaction rate. 
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